Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
最新数据
HK$2.02
+HK$0.095 · +4.94%
盘中时间采用HKT。市场数据可能有所延迟。
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
日内区间
当前HK$2.02
52周区间
当前HK$2.02
盘中时间采用HKT。市场数据可能有所延迟。
Sisram Medical Ltd, an investment holding company headquartered in Caesarea, Israel, since its establishment in 2013, is engaged in the creation, production, and worldwide distribution of a broad spectrum of medical solutions. The company develops and markets energy-based aesthetic devices, minimally invasive therapeutic systems, non-energy-dependent equipment, and cosmeceuticals, reaching markets across Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. Its comprehensive range of products and treatments addresses numerous conditions, such as hair removal, skin revitalization, acne and scarring, body and facial sculpting, pigment and skin surface refinement, fat transfer procedures, injectable dermal fillers, skin tissue regeneration injectables, personal wellness items, cosmetic dental procedures, transdermal delivery methods, cellulite reduction, stretch mark amelioration, therapy for vascular and pigmented lesions, hydradermabrasion, non-surgical eyelid lifts (blepharoplasty), liposuction, as well as feminine health and sexual well-being applications. Furthermore, the company is involved in the manufacturing, distribution, and sales of general medical apparatus. Sisram Medical's offerings are available under its prominent brand names, which include Alma, Soprano, Harmony, Copulla, Foshion, Accent, and LMNT.
日内区间
当前HK$2.02
52周区间
当前HK$2.02
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3.65亿 USD | 3.49亿 USD | 3.59亿 USD | 3.54亿 USD | 2.94亿 USD |
| 销货成本 | 1.5亿 USD | 1.32亿 USD | 1.4亿 USD | 1.52亿 USD | 1.27亿 USD |
| 毛利 | 2.15亿 USD | 2.17亿 USD | 2.2亿 USD | 2.02亿 USD | 1.67亿 USD |
| 研究与开发 | 1686.1万 USD | 1593.7万 USD | 1802.9万 USD | 1802.3万 USD | 1559.4万 USD |
| 销售、一般及管理费用 | 1.66亿 USD | 1.65亿 USD | 1.59亿 USD | 1.29亿 USD | 1.01亿 USD |
| 营业费用 | 1.83亿 USD | 1.81亿 USD | 1.77亿 USD | 1.47亿 USD | 1.16亿 USD |
| 利息收入 | 96.24万 USD | 79万 USD | 22.2万 USD | 61.3万 USD | 54.3万 USD |
| 利息支出 | 324.98万 USD | 245.5万 USD | 206.4万 USD | 197.2万 USD | 200.5万 USD |
| 折旧和摊销 | 1734.9万 USD | 1730.6万 USD | 1423.5万 USD | 1240.2万 USD | 1228.5万 USD |
| 营业利润 | 3255.5万 USD | 3565.7万 USD | 4205.9万 USD | 5544.4万 USD | 5055.9万 USD |
| 净利润 | 1901.6万 USD | 2512.6万 USD | 3149.9万 USD | 4017万 USD | 3124.5万 USD |
公司数据更新于 2026年10月9日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
HK$0.126
2025年(完整年度)+80.0% 自从 2021
2026年(部分年度):HK$0.095
HK$0.07
2,021
HK$0.157
2,022
HK$0.173
2,023
HK$0.158
2,024
HK$0.126
2,025
HK$0.095
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月26日 | HK$0.095Annual | 2026年8月27日 | 2026年9月11日 |
股息 | 2025年8月26日 | HK$0.126Annual | 2025年8月27日 | 2025年9月9日 |
股息 | 2024年8月26日 | HK$0.158Annual | 2024年8月27日 | 2024年9月9日 |
股息 | 2023年8月24日 | HK$0.173Annual | 2023年8月25日 | 2023年9月7日 |
股息 | 2022年8月19日 | HK$0.157Annual | 2022年8月22日 | 2022年9月2日 |
股息 | 2021年8月12日 | HK$0.07Annual | 2021年8月13日 | 2021年8月31日 |
除息 2026年8月26日
HK$0.095
Annual
2026年8月27日登记 · 支付日 2026年9月11日
除息 2025年8月26日
HK$0.126
Annual
2025年8月27日登记 · 支付日 2025年9月9日
除息 2024年8月26日
HK$0.158
Annual
2024年8月27日登记 · 支付日 2024年9月9日
除息 2023年8月24日
HK$0.173
Annual
2023年8月25日登记 · 支付日 2023年9月7日
除息 2022年8月19日
HK$0.157
Annual
2022年8月22日登记 · 支付日 2022年9月2日
除息 2021年8月12日
HK$0.07
Annual
2021年8月13日登记 · 支付日 2021年8月31日
报告持有此股票敞口的交易所交易基金。
WisdomTree International SmallCap Dividend FundDLS18.19万0.02%10.49亿 USD0.58%US$85.315-0.54%
WisdomTree Dynamic International SmallCap Equity ETFDDLS7.19万0.02%4.19亿 USD0.48%US$44.42-0.43%
WisdomTree Dynamic International Equity FundDDWM4.1万0.00%14.3亿 USD0.40%US$45.330.00%
Avantis International Small Cap Value ETFAVDV4794.45—199.94亿 USD0.36%US$107.72-0.31%
WisdomTree International SmallCap Dividend FundDLS
WisdomTree Dynamic International SmallCap Equity ETFDDLS
WisdomTree Dynamic International Equity FundDDWM
Avantis International Small Cap Value ETFAVDVAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。